To gain mechanistic insights as to how NRF2 activation in cancer cells induces low immune cell infiltration into tumor tissues, we investigated changes in gene expression in WT, KEAP1-KO, and DKO cancer cells. This evidence concerns the gene NFE2L2 and neoplasm.